| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;96:3921-3927.)
© 1997 American Heart Association, Inc.
Articles |
Adenosine-Induced Atrioventricular Block in Patients With Unexplained Syncope
The Diagnostic Value of ATP Testing
From the Section of Arrhythmology, Ospedali Riuniti, Lavagna (M.B., G.G., L.G., A.B., D.O., A.D.R.), and the Department of Cardiology and Arrhythmologic Center, Ospedale S. Maria Nuova, Reggio Emilia (C.M., N.B., G.L., G.P.), Italy.
Correspondence to Michele Brignole, MD, Via A. Grilli 164, 16041 Borzonasca (GE), Italy. E-mail brignole{at}omninet.it
Background ATP and its related nucleoside, adenosine, are ubiquitous biological compounds with potent depressant activity on the atrioventricular node. We hypothesized that an increased susceptibility of the atrioventricular node to adenosine may, in some cases, play a role in the genesis of syncope.
Methods and Results The study was performed in two parts.
In part 1, we evaluated the effects of a bolus injection of 20 mg ATP
in a group of 60 patients (57±19 years, 31 men) with syncope of
unexplained origin and in 90 control subjects without syncope (55±17
years, 46 men). In control subjects, the upper 95th percentile of the
maximum RR interval distribution, during ATP-induced
atrioventricular block (AVB), was 6000 ms. In the
syncope group, 28% of patients had a maximum RR interval above this
limit (P=.000). The distribution of the maximum RR
interval below the 95th percentile was similar in the two groups. In
part 2, we validated the ATP test in 24 patients who had the fortuitous
ECG recording of a spontaneous syncope caused by a transient
asystolic pause (AVB in 15 and sinus arrest in 9). The ATP test
caused AVB with an asystolic pause of 
6000 ms in 53% of the
patients with documented AVB but in none (0%) of the patients with
documented sinus arrest (P=.01). Among the patients with
spontaneous AVB, the ATP test was abnormal in 6 of the 7 patients
(86%) in whom all conventional investigations for syncope had been
negative and in 2 of the 8 patients (25%) who had shown positivity
(P=.03).
Conclusions An increased susceptibility to ATP testing is present in patients with SUO and patients with syncope due to paroxysmal AVB. Thus, a logical inference is that ATP testing can be used to identify patients with syncope due to paroxysmal AVB. The results of this study form the necessary background for future prospective studies with an aim to validate this assumption.
Key Words: adenosine • syncope • heart block • atrioventricular node
This article has been cited by other articles:
 |
|
 |
|
  S.W. Parry, T. Chadwick, J.C. Gray, R.S. Bexton, M. Tynan, J.P. Bourke, and S. Nath The intravenous adenosine test: a new test for the identification of bradycardia pacing indications? A pilot study in subjects with bradycardia pacing indications, vasovagal syncope and controls QJM, July 1, 2009; 102(7): 461 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brignole Different electrocardiographic manifestations of the cardioinhibitory vasovagal reflex Europace, February 1, 2009; 11(2): 144 - 146. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brignole, J.-J. Blanc, R. Sutton, and A. Moya CHAPTER 26 Syncope ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF]
|
|
|
|
|
|
S. Viskin, D. Justo, and A. Halkin Should the 'adenosine-challenge test' be part of the routine work-up for syncope? Europace, August 1, 2007; 9(8): 557 - 558. [Full Text] [PDF]
|
|
|
|
|
|
N. Fragakis, I. Iliadis, E. Sidopoulos, A. Lambrou, E. Tsaritsaniotis, and G. Katsaris The value of adenosine test in the diagnosis of sick sinus syndrome: susceptibility of sinus and atrioventricular node to adenosine in patients with sick sinus syndrome and unexplained syncope Europace, August 1, 2007; 9(8): 559 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brignole, R. Sutton, C. Menozzi, R. Garcia-Civera, A. Moya, W. Wieling, D. Andresen, D. G. Benditt, N. Grovale, T. De Santo, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope Eur. Heart J., September 2, 2006; 27(18): 2232 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Parry, S. Nath, J. P. Bourke, R. S. Bexton, and R. A. Kenny Adenosine test in the diagnosis of unexplained syncope: marker of conducting tissue disease or neurally mediated syncope? Eur. Heart J., June 2, 2006; 27(12): 1396 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Deharo, C. Jego, A. Lanteaume, and P. Djiane An Implantable Loop Recorder Study of Highly Symptomatic Vasovagal Patients: The Heart Rhythm Observed During a Spontaneous Syncope Is Identical to the Recurrent Syncope But Not Correlated With the Head-Up Tilt Test or Adenosine Triphosphate Test J. Am. Coll. Cardiol., February 7, 2006; 47(3): 587 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Perennes, M. Fatemi, M. L. Borel, Y. Lebras, C. L'Her, and J.-J. Blanc Epidemiology, Clinical Features, and Follow-Up of Patients With Syncope and a Positive Adenosine Triphosphate Test Result J. Am. Coll. Cardiol., February 7, 2006; 47(3): 594 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology Europace, January 1, 2004; 6(6): 467 - 537. [Full Text] [PDF]
|
|
|
|
|
|
G.N. Theodorakis, E.G. Livanis, D. Leftheriotis, P. Flevari, M. Markianos, and D.Th. Kremastinos Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol Eur. Heart J., April 1, 2003; 24(7): 658 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Garcia-Civera, R. Ruiz-Granell, S. Morell-Cabedo, R. Sanjuan-Manez, F. Perez-Alcala, E. Plancha, A. Navarro, S. Botella, and A. LLacer Selective use of diagnostic tests inpatients with syncope of unknown cause J. Am. Coll. Cardiol., March 5, 2003; 41(5): 787 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Donateo, M. Brignole, C. Menozzi, N. Bottoni, P. Alboni, M. Dinelli, A. Del Rosso, F. Croci, D. Oddone, A. Solano, et al. Mechanism of syncope in patients with positive adenosine triphosphate tests J. Am. Coll. Cardiol., January 1, 2003; 41(1): 93 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Steering Committee of the ISSUE 2 study International Study on Syncope of Uncertain Etiology 2: the management of patients with suspected or certain neurally mediated syncope after the initial evaluation Rationale and study design Europace, January 1, 2003; 5(3): 317 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brignole, P. Donateo, and C. Menozzi The diagnostic value of ATP testing in patients with unexplained syncope Europace, January 1, 2003; 5(4): 425 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Saadjian, S. Levy, F. Franceschi, I. Zouher, F. Paganelli, and R. P. Guieu Role of Endogenous Adenosine as a Modulator of Syncope Induced During Tilt Testing Circulation, July 30, 2002; 106(5): 569 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al. Guidelines on management (diagnosis and treatment) of syncope Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306. [Abstract] [PDF]
|
|
|
|
|
|
S. Viskin, R. Fish, A. Glick, M. Glikson, M. Eldar, and B. Belhassen The adenosine triphosphate test: a bedside diagnostic tool for identifying the mechanism of supraventricular tachycardia in patients with palpitations J. Am. Coll. Cardiol., July 1, 2001; 38(1): 173 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Alboni, M. Brignole, C. Menozzi, A. Raviele, A. Del Rosso, M. Dinelli, A. Solano, and N. Bottoni Diagnostic value of history in patients with syncope with or without heart disease J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1921 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. BRIGNOLE, C. MENOZZI, A. MOYA, and R. GARCIA-CIVERA Implantable loop recorder: towards a gold standard for the diagnosis of syncope? Heart, June 1, 2001; 85(6): 610 - 612. [Full Text]
|
|
|
|
|
|
M Brignole, G Gaggioli, C Menozzi, A Del Rosso, S Costa, A Bartoletti, N Bottoni, and G Lolli Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope Heart, January 1, 2000; 83(1): 24 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Benditt, G. J. Fahy, K. G. Lurie, S. Sakaguchi, W. Fabian, and N. Samniah Pharmacotherapy of Neurally Mediated Syncope Circulation, September 14, 1999; 100(11): 1242 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Flammang, M. Erickson, S. McCarville, T. Church, D. Hamani, and E. Donal Contribution of Head-Up Tilt Testing and ATP Testing in Assessing the Mechanisms of Vasovagal Syndrome : Preliminary Results and Potential Therapeutic Implications Circulation, May 11, 1999; 99(18): 2427 - 2433. [Abstract] [Full Text] [PDF]
|
|